Daiichi Sankyo Selects TrackWise Digital to Enable Digital Quality Management Across Pharmaceutical Operations

 
 

Leading pharmaceutical company embarks on the digital transformation of quality processes to streamline operations across its global supply chain

HAMILTON, NJ – APRIL 5, 2021 – Today, Sparta Systems announced that Daiichi Sankyo, a leading global pharmaceutical company and the second-largest pharmaceutical company in Japan has chosen TrackWise Digital® as its global end-to-end digital quality management platform. Daiichi Sankyo will implement TrackWise Digital to digitally connect and transform quality across global operations in North and South America, Europe and Asia.

“We wanted a digital solution that would bring together our quality, key applications and global teams – everyone who touches quality, into a single, robust solution,” said Judy Coddington, Vice President, Quality Assurance Daiichi Sankyo Inc. “With Sparta’s deep expertise in quality management and innovative digital quality platform, we not only have the right solution to give us full visibility of quality topics across all businesses and the entire product lifecycle but the right partner to support our future growth and product pipeline.“

With TrackWise Digital, Daiichi Sankyo will modernize its approach to quality by streamlining the development and delivery of innovative drug therapies and services to patients worldwide. The company will expand QMS capabilities to include Quality Events and Complaint Handling, CAPA, Global Change Control, Audit Management and Supplier Quality Management. TrackWise Digital’s interoperable platform allows Daiichi Sankyo to quickly integrate with its internal IT ecosystem and enable real-time, remote collaboration among its global teams and suppliers.

Oxana Pickeral, President and CEO of Sparta Systems said, “Companies like Daiichi Sankyo, who have a passion for innovation and improving patient safety, inspire us. Sparta is thrilled to be a part of Daiichi Sankyo’s forward-looking digital transformation strategy and provide the quality management platform in their pursuit of delivering high-quality, groundbreaking medicines to the market and patients in need.”

About Daiichi Sankyo:

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. For more information, please visit www.daiichisankyo.com.

About Sparta Systems

Sparta Systems, a Honeywell company, is the provider of TrackWise® enterprise QMS software and TrackWise Digital®, a next-generation, cloud and digital QMS SaaS platform. Sparta’s TrackWise Digital combined with Honeywell’s software solutions, batch automation, and data integration capabilities form an integrated life sciences manufacturing digital eco-system that enables greater efficiency and agility while helping achieve quality system compliance and reduced risk. The combination of Sparta Systems and Honeywell brings together Sparta Systems’ quality management leadership with over 100 years of software and industrial expertise from Honeywell. Together, Sparta and Honeywell will shape the future of digital quality and operational excellence for the life sciences industry.